Soros Fund Management’s Kite Pharma, Inc. KITE Stock Holding History

Soros Fund Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-660,148	Closed	-$38.1M	–	311
2015 Q1	$38.1M	Sell	660,148 -20,000	-3%	-$1.34M	0.37%	71
2014 Q4	$39.2M	Buy	680,148 +20,000	+3%	+$842K	0.43%	71
2014 Q3	$18.8M	Buy	+660,148	New	+$16.3M	0.14%	122

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Soros Fund Management's KITE Position: Q2 2015 in Review

Soros Fund Management sold out of Kite Pharma, Inc. (KITE) in Q2 2015, closing a stake of 660,148 shares — an estimated $38.1M sold.

Soros Fund Management first reported a position in KITE in Q3 2014 and held it in 3 quarters. The position peaked at $39.2M in Q4 2014. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

Soros Fund Management reported no remaining Kite Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
Soros Fund Management sold 660,148 Kite Pharma, Inc. shares in Q2 2015, an estimated $38.1M.
Soros Fund Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 3 quarters.
Soros Fund Management's Kite Pharma, Inc. position peaked at $39.2M in Q4 2014.
155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on Soros Fund Management's 13F filing for Q2 2015, filed 14 Aug 2015.